Low-Dose Oral Granisetron (1 mg) plus Intravenous Dexamethasone: Efficacy in Gynecologic Cancer Patients Receiving Carboplatin-Based Chemotherapy

By Markman M.   Kennedy A.   Webster K.   Kulp B.   Peterson G.   Belinson J.  

Gynecologic Oncology, Vol. 71, Iss. 1, 1998-10 ,pp. : 113-115

Elsevier

Access to resources Recommend Favorite

Randomised comparison of ondansetron plus dexamethasone with dexamethasone alone for the control of delayed cisplatin-induced emesis

By Tsukada H.   Hirose T.   Yokoyama A.   Kurita Y.  

European Journal of Cancer, Vol. 37, Iss. 18, 2001-12 ,pp. : 2398-2404

Elsevier

Access to resources Recommend Favorite

Comparison of Granisetron Alone and Granisetron Plus Hydroxyzine Hydrochloride for Prophylactic Treatment of Emesis Induced by Cisplatin Chemotherapy

By Tsukuda M.   Furukawa S.   Kokatsu T.   Enomoto H.   Kubota A.   Furukawa M.  

European Journal of Cancer, Vol. 31, Iss. 10, 1995-09 ,pp. : 1647-1649

Elsevier

Access to resources Recommend Favorite

A double-blind, crossover, randomized dose-comparison trial of granisetron for the prevention of acute and delayed nausea and emesis in children receiving moderately emetogenic carboplatin-based chemotherapy

By Berrak Su  

Supportive Care in Cancer, Vol. 15, Iss. 10, 2007-10 ,pp. : 1163-1168

Springer Publishing Company

Access to resources Recommend Favorite

Tropisetron, Ondansetron, and Granisetron for Control of Chemotherapy-Induced Emesis in Turkish Cancer Patients: A Comparison of Efficacy, Side-Effect Profile, and Cost

By Abali Huseyin   Celik Ismail  

Cancer Investigation, Vol. 25, Iss. 3, 2007-04 ,pp. : 135-139

Informa Healthcare

Access to resources Recommend Favorite